Talis Biomedical Corporation

OTCPK:TLIS Stock Report

Market Cap: US$3.6m

Talis Biomedical Past Earnings Performance

Past criteria checks 0/6

Talis Biomedical has been growing earnings at an average annual rate of 2%, while the Medical Equipment industry saw earnings growing at 11.5% annually. Revenues have been declining at an average rate of 76% per year.

Key information

2.0%

Earnings growth rate

8.1%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-76.0%
Return on equity-104.9%
Net Margin-12,506.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

We're A Little Worried About Talis Biomedical's (NASDAQ:TLIS) Cash Burn Rate

Aug 16
We're A Little Worried About Talis Biomedical's (NASDAQ:TLIS) Cash Burn Rate

Talis Biomedical reports Q2 results

Aug 02

Talis Biomedical Aims For Manufacturing Turnaround

Mar 17

Talis Biomedical (NASDAQ:TLIS) Will Have To Spend Its Cash Wisely

Feb 08
Talis Biomedical (NASDAQ:TLIS) Will Have To Spend Its Cash Wisely

Is Talis Biomedical (NASDAQ:TLIS) In A Good Position To Deliver On Growth Plans?

Nov 04
Is Talis Biomedical (NASDAQ:TLIS) In A Good Position To Deliver On Growth Plans?

Is Talis Biomedical (NASDAQ:TLIS) In A Good Position To Deliver On Growth Plans?

Jul 21
Is Talis Biomedical (NASDAQ:TLIS) In A Good Position To Deliver On Growth Plans?

News Flash: 4 Analysts Think Talis Biomedical Corporation (NASDAQ:TLIS) Earnings Are Under Threat

May 18
News Flash: 4 Analysts Think Talis Biomedical Corporation (NASDAQ:TLIS) Earnings Are Under Threat

Talis Biomedical Corporation (NASDAQ:TLIS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 14
Talis Biomedical Corporation (NASDAQ:TLIS) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Revenue & Expenses Breakdown

How Talis Biomedical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:TLIS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-51260
31 Mar 241-57260
31 Dec 232-62250
30 Sep 232-75260
30 Jun 233-86290
31 Mar 233-98320
31 Dec 225-113370
30 Sep 225-115420
30 Jun 225-127460
31 Mar 224-165470
31 Dec 218-192420
30 Sep 218-208350
30 Jun 2117-199260
31 Mar 2118-144180
31 Dec 2011-91130
30 Sep 2012-1100
31 Dec 1942670
31 Dec 182-2150

Quality Earnings: TLIS is currently unprofitable.

Growing Profit Margin: TLIS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TLIS is unprofitable, but has reduced losses over the past 5 years at a rate of 2% per year.

Accelerating Growth: Unable to compare TLIS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: TLIS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.9%).


Return on Equity

High ROE: TLIS has a negative Return on Equity (-104.94%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies